Radiolabeled Somatostatin Analogues Therapy in Advanced Neuroendocrine Tumors: A Single Centre Experience

Table 7

Results of treatment responses tabulated on the basis of numbers of PRRT cycles.

Numbers of cycles	CR	PR	SD	PD^#
2-3 (11/59)	1/11 (9%)	5/11 (46%)	2/11 (18%)	3/11 (27%)
4-5 (35/59)	—	14/35 (40%)	17/35 (49%)	4/35 (11%)
>5 (10/59)	—	5/10 (50%)	5/10 (50%)	—

^#Three patients were treated with only one cycle.